During the past decade, Northwest Cancer Specialists, P.C. conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 44 clinical trials were completed, i.e. on average, 137.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Cancer Specialists, P.C." #1 sponsor was "Novartis Pharmaceuticals" with 10 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "Bristol-Myers Squibb" with 7 trials sponsored, "Pfizer" with 7 trials sponsored and "Alliance for Clinical Trials in Oncology" with 7 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Cancer Specialists, P.C." #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 3 trials as a collaborator, "GOG Foundation" with 3 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 3 trials as a collaborator and "US Oncology Research" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Cancer Specialists, P.C." are "Breast Cancer" (10 trials), "Metastatic Breast Cancer" (10 trials), "Ovarian Cancer" (6 trials), "Fallopian Tube Cancer" (5 trials) and "Advanced Breast Cancer" (4 trials). Many other conditions were trialed in "Northwest Cancer Specialists, P.C." in a lesser frequency.

Most popular intervention types in "Northwest Cancer Specialists, P.C." are "Drug" (77 trials), "Biological" (12 trials), "Other" (9 trials), "Radiation" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (7 trials), "Carboplatin" (6 trials), "Paclitaxel" (6 trials), "Placebo" (6 trials) and "cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Cancer Specialists, P.C." are 59 trials for "All" genders, 26 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Cancer Specialists, P.C.". undefined are not yet recruiting, 8 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in Northwest Cancer Specialists, P.C., undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Cancer Specialists, P.C., 10 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".